HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Preventing Lymphedema in Axillary Lymph Node Dissection
- Status
- TERMINATED
- Phase
- NA
Treating Patients With Melanoma and ALK Alterations With Ensartinib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists
- Status
- TERMINATED
- Phase
- NA
Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy
- Status
- TERMINATED
- Phase
- N/A
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)
- Status
- TERMINATED
- Phase
- PHASE1
Safety of Intranodal ECI-006 in Melanoma Patients
- Status
- TERMINATED
- Phase
- PHASE1
A Study of APR-246 in Combination With Dabrafenib in Resistant Patients With BRAF V600 Mutant Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
The Impact of Melanoma and Drug Treatment in the Real World
- Status
- COMPLETED
- Phase
- N/A
Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
- Status
- TERMINATED
- Phase
- N/A
Artificial Intelligence-assisted Evaluation of Pigmented Skin Lesions
- Status
- UNKNOWN
- Phase
- N/A
Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- N/A
Induction of Immune-mediated aBscOpal Effect thrOugh STEreotactic Radiation Therapy in Metastatic Melanoma Patients Treated by PD-1 + CTLA-4 Inhibitors (BOOSTER MELANOMA)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Continuous vs Intermittent Dabrafenib Plus Trametinib in BRAFV600 Mutant Stage 3 Unresectable or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
TNF in Melanoma Patients Treated With Immunotherapy
- Status
- COMPLETED
- Phase
- NA
Fecal Microbiota Transplant (FMT) in Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Dabrafenib and/or Trametinib Rollover Study
- Status
- RECRUITING
- Phase
- PHASE4
Suicide Plus Immune Gene Therapy for Advanced Melanoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1